Annals of Oncology

Editorials:

S. Aebi

Endometrial cancer: a frequent orphan disease
Ann Oncol 15: 1149-1150; doi:10.1093/annonc/mdh325
[Extract] [FREE Full Text] [PDF] [Request Permissions]

Reviews:

V. Eleutherakis-Papaiakovou, A. Bamias, and M. A. Dimopoulos

Thalidomide in cancer medicine
Ann Oncol 15: 1151-1160; doi:10.1093/annonc/mdh300
[Abstract] [FREE Full Text] [PDF] [Request Permissions]

M. S. Mano and A. Awada

Primary chemotherapy for breast cancer: the evidence and the future
Ann Oncol 15: 1161-1171; doi:10.1093/annonc/mdh302
[Abstract] [FREE Full Text] [PDF] [Request Permissions]

Original articles:

Gynecologic tumors:

G. F. Fleming, V. L. Filiaci, R. C. Bentley, T. Herzog, J. Sorosky, L. Vaccarello, and H. Gallion

Phase III randomized trial of doxorubicin + cisplatin versus doxorubicin + 24-h paclitaxel + filgrastim in endometrial carcinoma: a Gynecologic Oncology Group study
Ann Oncol 15: 1173-1178; doi:10.1093/annonc/mdh316
[Abstract] [FREE Full Text] [PDF] [Request Permissions]

Head and neck cancer:

B. Brockstein, D. J. Haraf, A. W. Rademaker, M. S. Kies, K. M. Stenson, F. Rosen, B. B. Mittal, H. Pelzer, B. B. Fung, M.-E. Witt, B. Wenig, L. Portugal, R. W. Weichselbaum, and E. E. Vokes

Patterns of failure, prognostic factors and survival in locoregionally advanced head and neck cancer treated with concomitant chemoradiotherapy: a 9-year, 337-patient, multi-institutional experience
Ann Oncol 15: 1179-1186; doi:10.1093/annonc/mdh308
[Abstract] [FREE Full Text] [PDF] [Request Permissions]

Lung cancer:

J. V. Heymach, D. H. Johnson, F. R. Khuri, H. Safran, L. L. Schlabach, F. Yunus, R. F. DeVore, III, P. M. De Porre, H. M. Richards, X. Jia, S. Zhang, and B. E. Johnson

Phase II study of the farnesyl transferase inhibitor R115777 in patients with sensitive relapse small-cell lung cancer
Ann Oncol 15: 1187-1193; doi:10.1093/annonc/mdh315
[Abstract] [FREE Full Text] [PDF] [Request Permissions]

D. Isla, C. Sarries, R. Rosell, G. Alonso, M. Domine, M. Taron, G. Lopez-Vivanco, C. Camps, M. Botia, L. Nuñez, M. Sanchez-Ronco, J. J. Sanchez, M. Lopez-Brea, I. Barneto, A. Paredes, B. Medina, A. Artal, and P. Lianes

Single nucleotide polymorphisms and outcome in docetaxel–cisplatin-treated advanced non-small-cell lung cancer
Ann Oncol 15: 1194-1203; doi:10.1093/annonc/mdh319
[Abstract] [FREE Full Text] [PDF] [Supplementary data] [Request Permissions]

Gastrointestinal tumors:

J. Souglakos, K. Syrigos, A. Potamianou, A. Polyzos, I. Boukovinas, N. Androulakis, Ch. Kouroussis, N. Vardakis, Ch. Christophilakis, A. Kotsakis, and V. Georgoulias

Combination of irinotecan (CPT-11) plus oxaliplatin (L-OHP) as first-line treatment in locally advanced or metastatic gastric cancer: a multicentre phase II trial
Ann Oncol 15: 1204-1209; doi:10.1093/annonc/mdh312
[Abstract] [FREE Full Text] [PDF] [Request Permissions]

F. Maindrault-Gbel, C. Tournigand, T. André, E. Carola, M. Mabro, P. Artru, C. Louvet, and A. de Gramont

Oxaliplatin reintroduction in patients previously treated with leucovorin, fluorouracil and oxaliplatin for metastatic colorectal cancer
Ann Oncol 15: 1210-1214; doi:10.1093/annonc/mdh305
[Abstract] [FREE Full Text] [PDF] [Request Permissions]

Hematologic malignancies:

A. J. M. Ferreri, E. Campo, A. Ambrosetti, F. Ilariucci, J. F. Seymour, R. Willemze, G. Arrigoni, G. Rossi, A. López-Guillermo, E. Berti, M. Eriksson, M. Federico, S. Cortelazzo, S. Govi, N. Frungillo, S. Dell'Oro, M. Lestani, S. Asioli, E. Pedrinis, M. Ungari, T. Motta, R. Rossi, T. Artusi, P. Iuzzolino, E. Zucca, F. Cavalli, and M. Ponzoni

Anthracycline-based chemotherapy as primary treatment for intravascular lymphoma
Ann Oncol 15: 1215-1221; doi:10.1093/annonc/mdh274
[Abstract] [FREE Full Text] [PDF] [Request Permissions]

J. Czyz, R. Dziadziuszko, W. Knopinska-Postuszuy, A. Hellmann, L. Kachel, J. Holowiecki, J. Gozdzik, J. Hansz, A. Avigdor, A. Nagler, M. Osowiecki, J. Walewski, P. Mensah, W. Jurczak, A. Skotnicki, M. Sedzimirska, A. Lange, W. Sawicki, K. Sulek, M. Wach, A. Dmoszynska, A. Kus, T. Robak, and K. Warzocha

Outcome and prognostic factors in advanced Hodgkin's disease treated with high-dose chemotherapy and autologous stem cell transplantation: a study of 341 patients
Ann Oncol 15: 1222-1230; doi:10.1093/annonc/mdh304
[Abstract] [FREE Full Text] [PDF] [Request Permissions]

C. Nabhan, L. Rundhaugen, M. Jatoi, M. B. Riley, L. Boehlke, L. C. Peterson, and M. S. Tallman

Gemtuzumab ozogamicin (Mylotarg^TM) is infrequently associated with sinusoidal obstructive syndrome/veno-occlusive disease
Ann Oncol 15: 1231-1236; doi:10.1093/annonc/mdh324
[Abstract] [FREE Full Text] [PDF] [Request Permissions]

Supportive care:

F. Dimeo, A. Schmittel, T. Fietz, S. Schwartz, P. Köhler, D. Böning, and E. Thiel

Physical performance, depression, immune status and fatigue in patients with hematological malignancies after treatment
Ann Oncol 15: 1237-1242; doi:10.1093/annonc/mdh314
[Abstract] [FREE Full Text] [PDF] [Request Permissions]

M. Keller, S. Sommerfeldt, C. Fischer, L. Knight, M. Riesbeck, B. Löwe, C. Herfarth, and T. Lehnert

Recognition of distress and psychiatric morbidity in cancer patients: a multi-method approach
Ann Oncol 15: 1243-1249; doi:10.1093/annonc/mdh318
[Abstract] [FREE Full Text] [PDF] [Request Permissions]

Miscellaneous tumors:

I. Dimopoulou, E. Efstathiou, A. Samakovli, U. Dafni, L. A. Moulopoulos, C. Papadimitriou, P. Lyberopoulos, E. Kastritis, C. Roussos, and M. A. Dimopoulos

A prospective study on lung toxicity in patients treated with gemcitabine and carboplatin: clinical, radiological and functional assessment
Ann Oncol 15: 1250-1255; doi:10.1093/annonc/mdh311
[Abstract] [FREE Full Text] [PDF] [Request Permissions]

M. P. W. A. Houben, W. J. Louwman, C. C. Tijssen, J. L. J. M. Teepen, C. M. van Duijn, and J. W. W. Coebergh

Hypertension as a risk factor for glioma? Evidence from a population-based study of comorbidity in glioma patients
Ann Oncol 15: 1256-1260; doi:10.1093/annonc/mdh306
[Abstract] [FREE Full Text] [PDF] [Request Permissions]

S. S. Yoon, N. H. Segal, A. B. Olshen, M. F. Brennan, and S. Singer

Circulating angiogenic factor levels correlate with extent of disease and risk of recurrence in patients with soft tissue sarcoma
Ann Oncol 15: 1261-1266; doi:10.1093/annonc/mdh309
[Abstract] [FREE Full Text] [PDF] [Request Permissions]

Clinical trials:

J. R. Goffin, C. Savage, D. Tu, L. Shepherd, T. J. Whelan, and I. A. Olivotto

The difference between study recommendations, stated policy, and actual practice in a clinical trial
Ann Oncol 15: 1267-1273; doi:10.1093/annonc/mdh303
[Abstract] [FREE Full Text] [PDF] [Request Permissions]

Phase I and pharmacokinetics:

J. Marshall, H. Chen, D. Yang, M. Figueira, K. B. Bouker, Y. Ling, M. Lippman, S. R. Frankel, and D. F. Hayes

A phase I trial of a Bcl-2 antisense (G3139) and weekly docetaxel in patients with advanced breast cancer and other solid tumors
Ann Oncol 15: 1274-1283; doi:10.1093/annonc/mdh317
[Abstract] [FREE Full Text] [PDF] [Request Permissions]

K. Mross, H. Richly, N. Schleucher, S. Korfee, M. Tewes, M. E. Scheulen, S. Seeber, T. Beinert, M. Schweigert, U. Sauer, C. Unger, D. Behringer, E. Brendel, C. G. Haase, D. Voliotis, and D. Strumberg

A phase I clinical and pharmacokinetic study of the camptothecin glycoconjugate, BAY 38-3441, as a daily infusion in patients with advanced solid tumors
Ann Oncol 15: 1284-1294; doi:10.1093/annonc/mdh313
[Abstract] [FREE Full Text] [PDF] [Request Permissions]

Letters to the Editor:

K. Fizazi, S. Culine, and I. Chen

Oxaliplatin in non-seminomatous germ-cell tumors
Ann Oncol 15: 1295; doi:10.1093/annonc/mdh307
[Extract] [FREE Full Text] [PDF] [Request Permissions]

A. Schmittel, K. Jahnke, E. Thiel, and U. Keilholz

Neomycin as secondary prophylaxis for irinotecan-induced diarrhea
Ann Oncol 15: 1296; doi:10.1093/annonc/mdh310
[Extract] [FREE Full Text] [PDF] [Request Permissions]

A. Smaradottir, D. Kapur, and S. Bilgrami

Unusual extramedullary relapse of CML
Ann Oncol 15: 1296-1297; doi:10.1093/annonc/mdh321
[Extract] [FREE Full Text] [PDF] [Request Permissions]

D. Bernardi, A. Giacalone, M. Spina, and U. Tirelli

Rituximab-CHOP or 2-weekly CHOP + G-CSF in aggressive lymphoma of the elderly?
Ann Oncol 15: 1298; doi:10.1093/annonc/mdh322
[Extract] [FREE Full Text] [PDF] [Request Permissions]

B. Jeremic

Reply to the article "Continuously infused carboplatin used as radiosensitizer in locally unresectable non-small-cell lung cancer: a multicenter phase III study", by Groen et al. (Ann Oncol 2004; 15: 427–432)
Ann Oncol 15: 1298-1299; doi:10.1093/annonc/mdh323
[Extract] [FREE Full Text] [PDF] [Request Permissions]

Book reviews:

Harry Schouten

Blood: Principles and Practice of Hematology, 2nd edition
Ann Oncol 15: 1301; doi:10.1093/annonc/mdh320
[Extract] [FREE Full Text] [PDF] [Request Permissions]

To see an article, click its [Full Text] or [PDF] link. To review many abstracts, check the boxes to the left of the titles you want, and click the 'Get All Checked Abstract(s)' button. To see one abstract at a time, click its [Abstract] link.